Development of a novel ligand that activates JAK2/STAT5 signaling through a heterodimer of prolactin receptor and growth hormone receptor

References

• Keeler C, Dannies PS, Hodsdon ME. The tertiary structure and backbone dynamics of human prolactin. J Mol Biol 2003, 328, 1105–1121.
   PubMed Web of Science ®Google Scholar
• Teilum K, Hoch JC, Goffin V, Kinet S, Martial JA, Kragelund BB. Solution structure of human prolactin. J Mol Biol 2005, 351, 810–823.
   PubMedGoogle Scholar
• de Vos AM, Ultsch M, Kossiakoff AA. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 1992, 255, 306–312.
   Google Scholar
• Chantalat L, Jones N, Korber F, Navaza J, Pavlovsky AG.The crystal-structure of wild-type growth-hormone at 2.5 angstrom resolution. Protein peptide Lett 1995, 2, 333–340.
   Web of Science ®Google Scholar
• Clackson T, Wells JA. A hot spot of binding energy in a hormone-receptor interface. Science 1995, 267, 383–386.
   PubMed Web of Science ®Google Scholar
• Walsh ST, Kossiakoff AA. Crystal structure and site 1 binding energetics of human placental lactogen. J Mol Biol 2006, 358, 773–784.
   Google Scholar
• Nicola NA, Hilton DJ. General classes and functions of four-helix bundle cytokines. Adv Protein Chem 1998, 52, 1–65.
   Google Scholar
• Sakal E, Bignon C, Grosclaude J, Kantor A, Shapira R, Leibovitch H, Helman D, Nespoulous C, Shamay A, et al. Large-scale preparation and characterization of recombinant ovine placental lactogen. J Endocrinol 1997, 152, 317–327.
   Google Scholar
• Byatt JC, Eppard PJ, Veenhuizen JJ, Curran TL, Curran DF, McGrath MF, Collier RJ. Stimulation of mammogenesis and lactogenesis by recombinant bovine placental lactogen in steroid-primed dairy heifers. J Endocrinol 1994, 140, 33–43.
   PubMed Web of Science ®Google Scholar
• Herman A, Bignon C, Daniel N, Grosclaude J, Gertler A, Djiane J. Functional heterodimerization of prolactin and growth hormone receptors by ovine placental lactogen. J Biol Chem 2000, 275, 6295–6301.
   Google Scholar
• Staten NR, Byatt JC, Krivi GG. Ligand-specific dimerization of the extracellular domain of the bovine growth hormone receptor. J Biol Chem 1993, 268, 18467–18473.
   Google Scholar
• Herman A, Helman D, Livnah O, Gertler A. Ruminant placental lactogens act as antagonists to homologous growth hormone receptors and as agonists to human or rabbit growth hormone receptors. J Biol Chem 1999, 274, 7631–7639.
   Google Scholar
• Warren WC, Byatt JC, Huynh M, Paik K, Pegg G, Staten NR. Evaluation of the somatogenic activity of bovine placental lactogen with cell lines transfected with the bovine somatotropin receptor. Life Sci 1999, 65, 2755–2767.
   Google Scholar
• Biener E, Martin C, Daniel N, Frank SJ, Centonze VE, Herman B, Djiane J, Gertler A. Ovine placental lactogen-induced heterodimerization of ovine growth hormone and prolactin receptors in living cells is demonstrated by fluorescence resonance energy transfer microscopy and leads to prolonged phosphorylation of signal transducer and activator of transcription (STAT)1 and STAT3. Endocrinology 2003, 144, 3532–3540.
   Google Scholar
• Gertler A, Biener E, Ramanujan KV, Djiane J, Herman B. Fluorescence resonance energy transfer (FRET) microscopy in living cells as a novel tool for the study of cytokine action. J Dairy Res 2005, 72, Spec No: 14–19.
   Google Scholar
• Gertler A, Djiane J. Mechanism of ruminant placental lactogen action: molecular and in vivo studies. Mol Genet Metab 2002, 75, 189–201.
   Google Scholar
• Noel S, Herman A, Johnson GA, Gray CA, Stewart MD, Bazer FW, Gertler A, Spencer TE. Ovine placental lactogen specifically binds to endometrial glands of the ovine uterus. Biol Reprod 2003, 68, 772–780.
   Google Scholar
• Dietz AB, Georges M, Threadgill DW, Womack JE, Schuler LA. Somatic cell mapping, polymorphism, and linkage analysis of bovine prolactin-related proteins and placental lactogen. Genomics 1992, 14, 137–143.
   Google Scholar
• Gootwine E, Yossafi S. Genetic mapping of the ovine placental lactogen gene to sheep chromosome 20. Anim Genet 1998, 29, 69.
   Google Scholar
• Cunningham BC, Ultsch M, De Vos AM, Mulkerrin MG, Clauser KR, Wells JA. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 1991, 254, 821–825.
   PubMed Web of Science ®Google Scholar
• Sundstrom M, Lundqvist T, Rodin J, Giebel LB, Milligan D, Norstedt G.Crystal structure of an antagonist mutant of human growth hormone, G120R, in complex with its receptor at 2.9 A resolution. J Biol Chem 1996, 271, 32197–32203.
   Google Scholar
• Kleinberg DL, Todd J. Evidence that human growth hormone is a potent lactogen in primates. J Clin Endocrinol Metab 1980, 51, 1009–1013.
   PubMed Web of Science ®Google Scholar
• Cunningham BC, Jhurani P, Ng P, Wells JA. Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. Science 1989, 243, 1330–1336.
   PubMed Web of Science ®Google Scholar
• Somers W, Ultsch M, De Vos AM, Kossiakoff AA. The X-ray structure of a growth hormone-prolactin receptor complex. Nature 1994, 372, 478–481.
   PubMedGoogle Scholar
• Ultsch MH, Somers W, Kossiakoff AA, de Vos AM. The crystal structure of affinity-matured human growth hormone at 2 A resolution. J Mol Biol 1994, 236, 286–299.
   PubMed Web of Science ®Google Scholar
• Cunningham BC, Wells JA. Rational design of receptor-specific variants of human growth hormone. Proc Natl Acad Sci USA 1991, 88, 3407–3411.
   PubMed Web of Science ®Google Scholar
• Kossiakoff AA, Somers W, Ultsch M, Andow K, Muller YA, De Vos AM. Comparison of the intermediate complexes of human growth hormone bound to the human growth hormone and prolactin receptors. Protein Sci 1994, 3, 1697–1705.
   Google Scholar
• Cunningham BC, Bass S, Fuh G, Wells JA. Zinc mediation of the binding of human growth hormone to the human prolactin receptor. Science 1990, 250, 1709–1712.
   PubMed Web of Science ®Google Scholar
• Dattani MT, Hindmarsh PC, Brook CG, Robinson IC, Weir T, Marshall NJ. Enhancement of growth hormone bioactivity by zinc in the eluted stain assay system. Endocrinology 1993, 133, 2803–2808.
   PubMed Web of Science ®Google Scholar
• Fuh G, Colosi P, Wood WI, Wells JA. Mechanism-based design of prolactin receptor antagonists. J Biol Chem 1993, 268, 5376–5381.
   Google Scholar
• Duda KM, Brooks CL. Differential effects of zinc on functionally distinct human growth hormone mutations. Protein Eng 2003, 16, 531–534.
   Google Scholar
• Langenheim JF, Tan D, Walker AM, Chen WY. Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists. Mol Endocrinol 2006, 20, 661–674.
   Google Scholar
• Yang N, Langenheim JF, Wang X, Jiang J, Chen WY, Frank SJ. Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering. Mol Endocrinol 2007, 22, 978–988.
   Google Scholar
• Ultsch M, de Vos AM. Crystals of human growth hormone-receptor complexes. Extracellular domains of the growth hormone and prolactin receptors and a hormone mutant designed to prevent receptor dimerization. J Mol Biol 1993, 231, 1133–1136.
   PubMed Web of Science ®Google Scholar
• Chen WY, Chen NY, Yun J, Wagner TE, Kopchick JJ. In vitro and in vivo studies of antagonistic effects of human growth hormone analogs. J Biol Chem 1994, 269, 15892–15897.
   PubMed Web of Science ®Google Scholar
• Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA. Rational design of potent antagonists to the human growth hormone receptor. Science 1992, 256, 1677–1680.
   PubMed Web of Science ®Google Scholar
• Cunningham BC, Lowman HB, Wells JA, Clark RG, Olson K, Fuh GG, inventors; Genentech Inc, assignee. Human growth hormone variants. United States patent 5849535, 1998.
   Google Scholar
• Goffin V, Bernichtein S, Carriere O, Bennett WF, Kopchick JJ, Kelly PA. The human growth hormone antagonist B2036 does not interact with the prolactin receptor. Endocrinology 1999, 140, 3853–3856.
   PubMed Web of Science ®Google Scholar
• Maamra M, Finidori J, Von Laue S, Simon S, Justice S, Webster J, Dower S, Ross R. Studies with a growth hormone antagonist and dual-fluorescent confocal microscopy demonstrate that the full-length human growth hormone receptor, but not the truncated isoform, is very rapidly internalized independent of Jak2-Stat5 signaling. J Biol Chem 1999, 274, 14791–14798.
   PubMed Web of Science ®Google Scholar
• Mellado M, Rodriguez-Frade JM, Kremer L, von Kobbe C, de Ana AM, Merida I, Martinez AC. Conformational changes required in the human growth hormone receptor for growth hormone signaling. J Biol Chem 1997, 272, 9189–9196.
   PubMed Web of Science ®Google Scholar
• Rui H, Djeu JY, Evans GA, Kelly PA, Farrar WL. Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. J Biol Chem 1992, 267, 24076–24081.
   Google Scholar
• Shiu RP, Elsholtz HP, Tanaka T, Friesen HG, Gout PW, Beer CT, Noble RL. Receptor-mediated mitogenic action of prolactin in a rat lymphoma cell line. Endocrinology 1983, 113, 159–165.
   PubMed Web of Science ®Google Scholar
• Decouvelaere C, Peyrat JP, Bonneterre J, Djiane J, Jammes H. Presence of the two growth hormone receptor messenger RNA isoforms in human breast cancer. Cell Growth Differ 1995, 6, 477–483.
   Google Scholar
• Fujikawa T, Kaneko H, Hibasami H, Sakaguchi K, Alam KS, Tanaka M, Nakashima K. Inverse effects of 20K and 22K human growth hormones on the growth of T-47D human breast cancer cells in culture and in nude mice. Biochem Mol Biol Int 1998, 46, 719–724.
   Google Scholar